Vontobel Holding Ltd. TRVI — TREVI THERAPEUTICS INC

Ownership history in Vontobel Holding Ltd.  ·  7 quarters on record

AI Ownership Summary

Vontobel Holding Ltd. reported TREVI THERAPEUTICS INC (TRVI) in 7 quarterly 13F filings from 2025 Q1 through 2026 Q3. The latest visible filing shows TRVI at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this TRVI ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Vontobel Holding Ltd.'s position in TREVI THERAPEUTICS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q3

TRVI was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2025 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q1 to 2026 Q3

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Vontobel Holding Ltd. held TRVI — position size vs. price
% of Fund (quarterly)    TRVI price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 7 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q3 ADDED — — — 10,173 +120 +1.2% 0.00% $146K 2026-10-16 $11.88
2026 Q2 REDUCED — — — 10,053 -362 -3.5% 0.00% $187K 2026-08-03 $17.90
2026 Q1 REDUCED — — — 10,415 -349 -3.2% 0.00% $124K 2026-05-08 $14.50
2025 Q4 REDUCED 50.8% -4.7% ✅ 10,764 -11,095 -50.8% 0.00% $135K 2026-02-13 $10.40
2025 Q3 REDUCED 12.2% +40.1% ❌ 21,859 -3,041 -12.2% 0.00% $200K 2025-10-15 $10.62
2025 Q2 REDUCED 20.6% +63.6% ❌ 24,900 -6,459 -20.6% 0.00% $136K 2025-07-23 $7.89
2025 Q1 INITIATED — — — 31,359 — — 0.00% $197K 2025-04-28 $6.59

FAQ About Vontobel Holding Ltd. and TRVI

These are the practical questions this page is built to answer before you even open the full history table.

How long has Vontobel Holding Ltd. reported owning TRVI?

Vontobel Holding Ltd. reported TRVI across 7 quarterly 13F filings, from 2025 Q1 through 2026 Q3.

What was the largest reported TRVI position in Vontobel Holding Ltd.'s portfolio?

The largest reported portfolio weight for TRVI was 0.00% in 2025 Q1.

What is the latest reported TRVI position on this page?

The most recent filing on this page is 2026 Q3, when Vontobel Holding Ltd. reported 10,173 shares, equal to 0.00% of portfolio, with an estimated market value of $146K.

What does the chart on this TRVI ownership page compare?

The chart compares Vontobel Holding Ltd.'s quarterly TRVI portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Vontobel Holding Ltd. time their TRVI position?

Based on 13F filing dates vs. subsequent TRVI price moves, Vontobel Holding Ltd. correctly timed 3 out of 6 reported position changes (50%). The annualised alpha on TRVI relative to SPY over the holding period was +18.3%.

← Back to Vontobel Holding Ltd. Holdings